ArticleBMC women's health2025
Determinants of abortion among women of reproductive age in Ghana: multilevel analysis evidence from the 2022 Ghana demographic and health survey.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and determinants of obesity among women aged 15-49 years in the Ashanti region, Ghana: Analysis of the 2022 Ghana demographic and health survey.SAGE open medicine · 2026Article
- Abortion safety in Ghana: does motivation matter?BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDue to data gaps in most countries, the factors that affect the prevalence of abortion among women from a variety of social and economic backgrounds, especially in Africa, are little understood. We investigated abortion and its determinants among women of reproductive age in this study with the aim of providing policymakers in Ghana specific information.
methodsAfter obtaining authorization to analyze data on abortion among women of reproductive age, we looked at the data from the Ghana demographic health survey 2022 that we obtained from the DHS website. We used binary logistic regression, both bivariate and multilevel. A three-level binary logistic regression analysis was performed on community and individual-level abortion predictors, using p-values less than 0.05 and adjusted odds ratios (AOR) with 95% confidence intervals (CI).
resultsIn the current study, the prevalence of abortion was 39.84%. Factors associated with abortion were age group 20-24 (AOR = 1.65, 95%CI = 1.05-2.61), 25-29 (AOR = 2.55, 95%CI = 1.60-4.08), 30-34 (AOR = 2.97, 95%CI = 1.54-4.81), 35-39 (AOR = 2.54, 95%CI = 1.54-4.17), 40-44 (AOR = 4.73, 95%CI = 2.74-8.15), 45-49 (AOR = 4.73, 95%CI = 2.21-9.45), married women (AOR = 1.48, 95%CI = 1.07-2.04), women living with their partner (AOR = 1.42, 95%CI = 1.02-1.98), intention to use contraceptives (AOR = 0.73, 95%CI = 0.61-0.88), smokers (AOR = 0.05, 95%CI = 0.06-0.43), Northern region (AOR = 0.50, 95%CI = 0.26-0.96), North East region (AOR = 0.26, 95%CI = 0.11-0.59), Upper East region (AOR = 0.33, 95%CI = 0.16-0.71), and Upper West region (AOR = 0.29, 95%CI = 0.12-0.67).
conclusionThe magnitude of abortion was relatively higher than that of other African countries including Mozambique, Ghana, Côte d'Ivoire and Ethiopia. Education status, age, intention of using contraceptives, smoking, and region were determinants of abortion in Ghana. Therefore, comprehensive and culturally acceptable sexual and reproductive health services for women must be provided by those in charge. It is important to establish programs that support women's livelihood and education so that they can make educated decisions about things like using contraception and avoiding unintended pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.